Real-time enrollment status for this cidp (chronic inflammatory demyelinating polyradiculoneuropathy) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:43 AM UTC
| NCT Number | NCT07540221 |
| Recruiting Status | Recruiting |
| Condition | CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) |
| Phase | PHASE3 |
| Target Enrollment | 40 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Grifols Therapeutics LLC |
| Last Updated on CT.gov | July 8, 2026 (Jul 8, 2026) |
As of August 27, 2026: Clinical trial NCT07540221 is currently recruiting participants. This phase3 study for cidp (chronic inflammatory demyelinating polyradiculoneuropathy) is actively seeking new participants at 7 locations across the United States. The study is sponsored by Grifols Therapeutics LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07540221 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07540221 was last updated Jul 8, 2026 (July 8, 2026). HelloStudys verifies this status automatically.